Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Antibiotic-resistant gonorrhea
  • Published Date:
    7/13/16
  • Language:
    English
Filetype[PDF-104.85 KB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Impact of Rapid Susceptibility Testing and Antibiotic Selection Strategy on the Emergence and Spread of Antibiotic Resistance in Gonorrhea
    Personal Author:
    Tuite, Ashleigh R.; Gift, Thomas L.; Chesson, Harrell W.; Hsu, Katherine; Salomon, Joshua A.; Grad, Yonatan H.;
    Published Date:
    Nov 27 2017
    Source:
    J Infect Dis. 2017; 216(9):1141-1149.
    Description:
    BackgroundIncreasing antibiotic resistance limits treatment options for gonorrhea. We examined the impact of a hypothetical point-of-care (POC) test reporting antibiotic susceptibility profiles on slowing resistance spread.MethodsA mathematical model...
    File Type:
    Filetype[PDF - 854.69 KB]
  2. CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide : Georgia
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    12/21/17
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2017
    AR solutions In action
    Description:
    $6,555,608 Funding for AR Activities Fiscal Year 2017One of 10 sites for the Emerging Infections ProgramFunding to local health departments:$510,636 - RAPID DETECTION & RESPONSE to emerging drug-resistant germs is critical to contain the spread of th...
    File Type:
    Filetype[PDF - 845.04 KB]
  3. CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide : California
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    12/21/17
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2017
    AR solutions In action
    Description:
    $7,640,596 Funding for AR Activities Fiscal Year 2017One of 10 sites for the Emerging Infections ProgramCandida auris, a resistant fungus that can cause deadly infections, was identified in California. CDC provides California with resources to identi...
    File Type:
    Filetype[PDF - 728.76 KB]
  4. Combatting the treat of antibiotic-resistant gonorrhea
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention.
    Published Date:
    Revised August 9, 2017
    Description:
    Antibiotic resistance is the ability of bacteria to resist the e ects of drug treatment. Simply put, germs continue to multiply because the drugs cannot kill them. For more than 30 years, the U.S. Centers for Disease Control and Prevention (CDC) has ...
    File Type:
    Filetype[PDF - 416.87 KB]
  5. Addressing the threat of drug-resistant gonorrhea
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.)
    Published Date:
    July 2016
    Series:
    CDC fact sheet
    Description:
    Antibiotic resistance is threatening the effectiveness of gonorrhea treatment in the United States. Gonorrhea is one of the most common sexually transmitted diseases (STDs), with more than 800,000 infections estimated to occur in the United States ea...
    File Type:
    Filetype[PDF - 65.01 KB]